Loading patent…
OwnerAndrew Langeinventor
Estimating the term…
The present description broadly relates to compounds that have anti-fertility effects or the ability to inhibit human chorionic gonadotropin (hCG) in biological systems. This includes compounds both synthetic and non-synthetic, whose structure are derived from those of plants and other natural substances that have the ability to inhibit human chorionic gonadotropin in biological systems. Examples of these plants are, but are not limited to Azadirachta indica (neem), Gossypium herbaceum, Trichosanthes kirilowii, Hibiscus rosa-sinensis (Malvaceae), Momordica charantia and Scutellaria barbata. In some embodiments, the compounds can be used for the treatment of cancer and tumors which have biomarkers for chorionic antigens. In addition to the anti-hCG activities of the plant substances there may be additional or corollary actions which may contribute to their efficacy.
A method of treating cancer, the method comprising administering a compound to a subject in need thereof, wherein the compound is an anti-hCG compound, wherein the compound is an anti-hCG compound in one or more of Azadirachta indica (neem), Gossypium herbaceum, Trichosanthes kirilowii, Hibiscus rosa-sinensis (Malvaceae), Momordica charantia or Scutellaria barbata, and wherein the compound is administered in an amount that is adequate to treat cancer.
A method of treating cancer, the method comprising administering an herbal substance to boost immune system in a subject, wherein the herbal substance comprises an anti-hCG compound in one or more of Azadirachta indica (neem), Gossypium herbaceum, Trichosanthes kirilowii, Hibiscus rosa-sinensis (Malvaceae), Momordica charantia or Scutellaria barbata, wherein the anti-hCG compound is administered in an amount that is adequate to treat cancer.
A composition for treating cancer, wherein the composition is an herbal substance to boost immune system in a subject, wherein the herbal substance comprises an anti-hCG compound in one or more of Azadirachta indica (neem), Gossypium herbaceum, Trichosanthes kirilowii, Hibiscus rosa-sinensis (Malvaceae), Momordica charantia or Scutellaria barbata, and wherein the anti-hCG compound is administered in an amount that is adequate to treat cancer.
Dependencies are inferred from the claim text.